Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Preliminary results
Inv. presentation
Quarterly results
STANDARD BIOTOOLS INC. (FLDM) Create: Alert

All | News | Filings
Date FiledTypeDescription
10/04/2023 425 Form 425 - Prospectuses and communications, business combinations:
10/04/2023 425 Form 425 - Prospectuses and communications, business combinations:
10/04/2023 425 Form 425 - Prospectuses and communications, business combinations:
10/04/2023 425 Form 425 - Prospectuses and communications, business combinations:
10/04/2023 425 Form 425 - Prospectuses and communications, business combinations:
10/04/2023 425 Form 425 - Prospectuses and communications, business combinations:
10/04/2023 8-K Acquisition/merger/asset purchase announced
Docs: "AGREEMENT AND PLAN OF MERGER among SOMALOGIC, INC., STANDARD BIOTOOLS INC., and MARTIS MERGER SUB, INC.",
"Standard BioTools and SomaLogic to Combine in All-Stock Merger Creating a Diversified Leader in Life Sciences Tools",
"Investor Presentation",
"Form of Standard BioTools Inc. Voting Agreement for Series B-2 Preferred Stockholders",
"Form of Standard BioTools Inc. Voting Agreement for Directors and Officers",
"Form of SomaLogic, Inc. Voting Agreement"
08/23/2023 144 Form 144 - Report of proposed sale of securities:
08/17/2023 144 Form 144 - Report of proposed sale of securities:
08/11/2023 144 Form 144 - Report of proposed sale of securities:
08/08/2023 10-Q Quarterly Report for the period ended June 30, 2023
08/08/2023 8-K Quarterly results
Docs: "Standard BioTools Reports Second Quarter 2023 Financial Results Continued operational execution improves revenue growth, margin expansion,"
07/28/2023 8-K Quarterly results
07/07/2023 SC 13G/A PRIMECAP MANAGEMENT CO reports a 4.1% stake in Standard BioTools Inc.
07/03/2023 SC 13D/A Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
06/16/2023 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
Docs: "STANDARD BIOTOOLS INC. 2011 EQUITY INCENTIVE PLAN STANDARD BIOTOOLS INC. 2011 EQUITY INCENTIVE PLAN"
05/26/2023 SD Form SD - Specialized disclosure report:
05/15/2023 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
Docs: "Appendix A Standard BioTools Inc. 2020 Change of Control and Severance Plan Participation Agreement",
"STANDARD BIOTOOLS INC.",
"Available Information Standard BioTools uses its website , investor site , corporate Twitter account , Facebook page , and LinkedIn page as channels of distribution of information about its products, its planned financial and other announcements, its attendance at upcoming investor and industry conferences, and other matters. Such information may be deemed material information, and Standard BioTools may use these channels to comply with its disclosure obligations under Regulation FD. Therefore, investors should monitor Standard BioTools’ website and its social media accounts in addition to following its press releases, SEC filings, public conference calls, and webcasts."
05/09/2023 10-Q Quarterly Report for the period ended March 31, 2023
05/09/2023 8-K Quarterly results
Docs: "Standard BioTools Reports First Quarter 2023 Financial Results"
05/03/2023 8-K Quarterly results
04/28/2023 DEFA14A Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
04/28/2023 DEF 14A Form DEF 14A - Other definitive proxy statements:
03/16/2023 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
Docs: "Experienced Life Science Operating Leader Joins Board as Company Enters New Phase"
03/14/2023 10-K Annual Report for the period ended December 31, 2022
03/13/2023 8-K Other Events  Interactive Data
02/14/2023 SC 13G/A VIKING GLOBAL INVESTORS LP reports a 9.5% stake in Standard BioTools Inc.
02/14/2023 SC 13G/A Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
02/09/2023 SC 13G PRIMECAP MANAGEMENT CO reports a 5.8% stake in Standard BioTools Inc.
02/09/2023 SC 13G/A VANGUARD GROUP INC reports a 5% stake in Standard BioTools Inc.
01/09/2023 8-K Quarterly results
12/30/2022 SC 13D/A Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
11/28/2022 8-K Quarterly results
11/14/2022 SC 13G/A Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy